Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
March 24, 2023
Design, Synthesis, and Biological Evaluation of Androgen Receptor (AR) Antagonist-Heat Shock Protein 90 (Hsp90) Inhibitor Conjugates for Targeted Therapy of Castration-Resistant Prostate Cancer
Siqi Zhang, Xiaolei Meng, Sai Zhang, et al.
Journal of Medicinal Chemistry
|
September 11, 2023
Novel Sulfonylurea-Based NLRP3 Inflammasome Inhibitor for Efficient Treatment of Nonalcoholic Steatohepatitis, Endotoxic Shock, and Colitis
Zhuoyue Li, Yiming Chen, Xiaolin Jiang, et al.
Nature Chemistry
|
June 5, 2026
Catalytic endo-stereoselective [2+2] cycloaddition of norbornadienes with internal alkynes
Longji Dai, Gufeng Yin, Zekun Tuo, et al.
Acta Biochimica Et Biophysica Sinica
|
February 20, 2020
Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma
Xinying Xue, Chen Wang, Zhiqiang Xue, et al.
Journal of Medicinal Chemistry
|
September 2, 2021
Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
Weiguo Xiang, Lijie Zhao, Xin Han, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 28, 2020
Virus Disinfection from Environmental Water Sources Using Living Engineered Biofilm Materials
Jiahua Pu, Yi Liu, Jicong Zhang, et al.
Journal of Medicinal Chemistry
|
May 29, 2026
Discovery of an Androgen Receptor Degrader Featuring a Pyridazinyl Glutarimide CRBN-Binding Motif for Transdermal Treatment of Androgenetic Alopecia
Xiao Wang, Ling Ge, Yawei Yu, et al.
Journal of Medicinal Chemistry
|
June 29, 2023
Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
Xin Han, Lijie Zhao, Weiguo Xiang, et al.
Frontiers in Oncology
|
August 28, 2020
Catalog of Lung Cancer Gene Mutations Among Chinese Patients
Xinying Xue, Idorenyin Asuquo, Lei Hong, et al.
Journal of Medicinal Chemistry
|
September 8, 2023
Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer
Weiguo Xiang, Lijie Zhao, Xin Han, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
March 24, 2023
Design, Synthesis, and Biological Evaluation of Androgen Receptor (AR) Antagonist-Heat Shock Protein 90 (Hsp90) Inhibitor Conjugates for Targeted Therapy of Castration-Resistant Prostate Cancer
Siqi Zhang, Xiaolei Meng, Sai Zhang, et al.
Journal of Medicinal Chemistry
|
September 11, 2023
Novel Sulfonylurea-Based NLRP3 Inflammasome Inhibitor for Efficient Treatment of Nonalcoholic Steatohepatitis, Endotoxic Shock, and Colitis
Zhuoyue Li, Yiming Chen, Xiaolin Jiang, et al.
Nature Chemistry
|
June 5, 2026
Catalytic endo-stereoselective [2+2] cycloaddition of norbornadienes with internal alkynes
Longji Dai, Gufeng Yin, Zekun Tuo, et al.
Acta Biochimica Et Biophysica Sinica
|
February 20, 2020
Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma
Xinying Xue, Chen Wang, Zhiqiang Xue, et al.
Journal of Medicinal Chemistry
|
September 2, 2021
Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
Weiguo Xiang, Lijie Zhao, Xin Han, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 28, 2020
Virus Disinfection from Environmental Water Sources Using Living Engineered Biofilm Materials
Jiahua Pu, Yi Liu, Jicong Zhang, et al.
Journal of Medicinal Chemistry
|
May 29, 2026
Discovery of an Androgen Receptor Degrader Featuring a Pyridazinyl Glutarimide CRBN-Binding Motif for Transdermal Treatment of Androgenetic Alopecia
Xiao Wang, Ling Ge, Yawei Yu, et al.
Journal of Medicinal Chemistry
|
June 29, 2023
Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer
Xin Han, Lijie Zhao, Weiguo Xiang, et al.
Frontiers in Oncology
|
August 28, 2020
Catalog of Lung Cancer Gene Mutations Among Chinese Patients
Xinying Xue, Idorenyin Asuquo, Lei Hong, et al.
Journal of Medicinal Chemistry
|
September 8, 2023
Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer
Weiguo Xiang, Lijie Zhao, Xin Han, et al.
Page
of 8